Living with Bromhidrosis: What the Evidence Says and Practical Steps

A chronic odour that reshapes everyday life

When a condition makes a person avoid public transport, choose a seat far from others and spend thousands on products that never work, the impact reaches far beyond the skin. The Guardian recently reported on Hay Hayat’s decade‑long struggle with bromhidrosis – a persistent, often bacterial, body odour that can accompany excessive sweating. Understanding why the problem occurs, what options exist, and where the evidence stops, can help anyone facing a similar issue.

According to Health, bromhidrosis is usually linked to the apocrine glands that sit in the armpits, breasts and groin. These glands release a fatty, protein‑rich fluid that is odourless until skin bacteria break it down. When the balance of bacteria shifts, the breakdown products become noticeably smelly.

Why the apocrine system matters

Apocrine glands differ from the eccrine glands that regulate temperature through watery sweat. Their secretion contains lipids and steroids that provide a nutrient‑rich environment for microbes such as Corynebacterium and Staphylococcus species. In most people, a diverse microbial community keeps the odour level low. The evidence suggests that in bromhidrosis either the glands become overactive – producing more substrate – or the microbial community becomes dominated by odour‑producing strains.

Hormonal changes, especially the drop in oestrogen during menopause, can increase apocrine activity. Hayat’s experience of worsening odour after an oophorectomy aligns with this pattern. Medications, metabolic disorders and diet can also tip the balance, but the exact triggers often remain hidden, which is why a clear diagnostic threshold is lacking.

How current treatments try to restore balance

*Effectiveness varies between individuals and often depends on adherence and underlying cause.

What the alternatives bring – and what they cost

Topical approaches are the cheapest and easiest to access, but they also risk wiping out beneficial bacteria. Chris Callewaert warns that repeated use of strong antiperspirants may encourage the resurgence of more resilient, odour‑producing microbes. In contrast, laser or Botox directly reduces the surface area where bacteria thrive, but they require clinical appointments and can be pricey.

The miraDry device offers a permanent solution, yet the upfront expense limits its reach to those who can afford private care. NHS England currently does not fund miraDry for bromhidrosis, because the evidence base is still emerging and the condition lacks a formal diagnostic code.

Who stands to gain and who may be left behind

People with severe hyperhidrosis often qualify for NHS-funded antiperspirant prescriptions or Botox, but bromhidrosis alone rarely meets the criteria for referral. This creates a gap: sufferers who are not heavy sweaters may still experience crippling social anxiety yet receive little NHS support.

Private clinics profit from high‑cost interventions, while the broader public health system bears the indirect cost of lost productivity and mental‑health referrals. The trade‑off is clear – without a recognised pathway, many patients end up paying out of pocket for treatments that may only partially help.

The psychological loop that amplifies the problem

Callewaert’s research shows that anxiety about odour can lead to more intensive hygiene routines, which in turn disturb the skin microbiome and increase sweat. The evidence suggests a self‑reinforcing cycle: stress raises cortisol, which can stimulate apocrine activity; more odour fuels more stress.

Hayat’s story illustrates how the cycle can push someone to avoid public spaces, alter career choices and even consider suicide. While clinical interventions target the physical source, they do not automatically resolve the mental‑health fallout. The NHS’s mental‑health services can provide counselling, but referral rates are low because clinicians may not recognise bromhidrosis as a trigger for anxiety.

What could go wrong – gaps in the evidence

• Diagnostic uncertainty – No standard test exists to differentiate bromhidrosis from normal body odour. Clinicians rely on patient‑reported distress, which can vary widely.
• Long‑term safety of gland‑destroying devices – miraDry and extensive laser treatments permanently remove sweat glands. While studies report low complication rates, the long‑term impact on thermoregulation, especially in older adults, is not fully known.
• Microbiome rebound – Antibacterial products may lead to a rapid rebound of odour‑producing bacteria once use stops. Research on how to sustain a healthier microbial balance is still limited.
• Cost barriers – Private treatments are inaccessible to many, and the NHS has not yet incorporated bromhidrosis into its commissioning frameworks.
• Underlying disease signals – Strong odour can be an early sign of diabetes or Parkinson’s disease. Current guidelines advise clinicians to investigate persistent, unexplained odour, but this is not consistently applied.

A concrete step for this week

Try a simple change to your laundry routine: wash clothes at 60 °C (or the highest temperature the fabric allows) and add a cup of white vinegar to the final rinse. The heat kills residual skin bacteria, while vinegar helps neutralise odour molecules. Doing this for the next few washes can reduce the bacterial load on fabrics and may lessen the overall intensity of body odour.

Sources

• Health article on chronic body odour